Literature DB >> 10899498

Low serum estradiol concentrations after five days of controlled ovarian hyperstimulation for in vitro fertilization are associated with poor outcome.

Y Khalaf1, A Taylor, P Braude.   

Abstract

OBJECTIVE: To evaluate the prognostic significance of low serum E2 concentrations in controlled ovarian hyperstimulation (COH) cycles for IVF.
DESIGN: Retrospective study.
SETTING: Assisted conception unit of a university hospital. PATIENT(S): One thousand four hundred and forty patients undergoing COH for IVF. INTERVENTION(S): COH, serum E2 measurement, ultrasonographic scanning of ovarian follicles, oocyte retrieval, and ET. MAIN OUTCOME MEASURE(S): Cancellation and pregnancy rates. RESULT(S): Patients were classified into four groups according to serum E2 levels on the sixth day of COH: group A (E2 level < 50 pg/mL [114 cycles]), group B (E2 level 51-100 pg/mL [189 cycles]), group C (E2 level 101-200 pg/mL [320 cycles]), and group D (E2 level >200 pg/mL [817 cycles]). Group A experienced the highest cancellation rates (65.1%) and lowest pregnancy rates (7.8%) despite requiring significantly more hMG ampules (47.8+/-1.7). The cancellation rate was higher (75.1%) and no pregnancy occurred in a subset of group A in whom COH was initiated with > or =3 ampules (225 IU) of gonadotropins. CONCLUSION(S): In COH cycles using luteal phase buserelin, low initial serum E2 concentrations are associated with poor outcome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899498     DOI: 10.1016/s0015-0282(00)00569-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Serum estradiol:oocyte ratio as a predictor of reproductive outcome: an analysis of data from >9000 IVF cycles in the Republic of Ireland.

Authors:  Denis A Vaughan; Conor Harrity; E Scott Sills; Edgar V Mocanu
Journal:  J Assist Reprod Genet       Date:  2016-02-06       Impact factor: 3.412

2.  A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles.

Authors:  L A Kondapalli; T A Molinaro; M D Sammel; A Dokras
Journal:  Hum Reprod       Date:  2012-06-29       Impact factor: 6.918

3.  Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success.

Authors:  Sudha Prasad; Yogesh Kumar; Megha Singhal; Shashi Sharma
Journal:  J Obstet Gynaecol India       Date:  2014-02-27

4.  Hypo-glycosylated hFSH drives ovarian follicular development more efficiently than fully-glycosylated hFSH: enhanced transcription and PI3K and MAPK signaling.

Authors:  Guohua Hua; Jitu W George; Kendra L Clark; Kim C Jonas; Gillian P Johnson; Siddesh Southekal; Chittibabu Guda; Xiaoying Hou; Haley R Blum; James Eudy; Viktor Y Butnev; Alan R Brown; Sahithi Katta; Jeffrey V May; George R Bousfield; John S Davis
Journal:  Hum Reprod       Date:  2021-06-18       Impact factor: 6.353

5.  A multi-centre randomised controlled study of pre-IVF outpatient hysteroscopy in women with recurrent IVF implantation failure: Trial of Outpatient Hysteroscopy - [TROPHY] in IVF.

Authors:  Tarek El-Toukhy; Rudi Campo; Sesh Kamal Sunkara; Yacoub Khalaf; Arri Coomarasamy
Journal:  Reprod Health       Date:  2009-12-03       Impact factor: 3.223

6.  Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.

Authors:  Rodopiano S Florêncio; Melaynne S B Meira; Marcos V da Cunha; Mylena N C R Camarço; Eduardo C Castro; Marta C C F Finotti; Vinicius A de Oliveira
Journal:  JBRA Assist Reprod       Date:  2018-03-01

7.  Relationship between a low ratio of serum estradiol to follicle number and fertility treatment outcomes: A retrospective cohort study of 516 cases.

Authors:  Qiaoyao Huang; Yanru Niu; Lihua Xu; Bi Chen; Yunshan Zhang; Li Jun Song; Xia Jing; Bing Wei; Tianzhong Ma
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.